bromodeoxyuridine has been researched along with busulfan in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (25.00) | 18.7374 |
| 1990's | 1 (12.50) | 18.2507 |
| 2000's | 4 (50.00) | 29.6817 |
| 2010's | 1 (12.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
| Michalová, K; Musilová, J; Urban, J | 1 |
| Ohshio, I | 1 |
| Keller, R | 1 |
| Bates, SE; Holbeck, SL; Kohlhagen, G; Medina-Perez, W; Mertins, SD; Myers, TG; Pommier, Y; Wang, E | 1 |
| Guan, D; Harada, M; Naruse, T; Ogino, T; Otsuji, M; Takagi, M; Takahara, M; Zhe, P | 1 |
| Probin, V; Wang, Y; Zhou, D | 1 |
| Amidi, F; Khanlarkhani, N; Mortezaee, K; Najafi, A; Naji, M; Pasbakhsh, P; Sobhani, A; Zendedel, A | 1 |
8 other study(ies) available for bromodeoxyuridine and busulfan
| Article | Year |
|---|---|
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Sister-chromatid exchanges and chromosal breakage in patients treated with cytostatics.
Topics: Bromodeoxyuridine; Busulfan; Chromatids; Chromosome Aberrations; Cyclophosphamide; Doxorubicin; Fluorouracil; Humans; Neoplasms | 1979 |
[Quantitative analysis of DNA synthesis and cell condensation in the oligodactylic rat hand plate].
Topics: Abnormalities, Drug-Induced; Animals; Bromodeoxyuridine; Busulfan; Cell Count; DNA; Female; Foot; Forelimb; Gestational Age; Immunohistochemistry; Macrophages; Rats; Rats, Inbred Strains | 1992 |
[Localization and distribution of myleran-induced chromosome breaks in Vicia faba. I. The effect of 5-bromodeoxyuridine on chromosome aberration rate].
Topics: Bromodeoxyuridine; Busulfan; Chromosome Aberrations; Plants | 1968 |
In vitro evaluation of dimethane sulfonate analogues with potential alkylating activity and selective renal cell carcinoma cytotoxicity.
Topics: Alkylating Agents; Animals; Bromodeoxyuridine; Busulfan; Carcinoma, Renal Cell; Carmustine; Cell Cycle; DNA Damage; Drug Evaluation, Preclinical; Drug Resistance, Neoplasm; Humans; Inhibitory Concentration 50; Kidney Neoplasms; Mesylates; Rats; Tumor Suppressor Protein p53; Yeasts | 2004 |
Developmental abnormalities in rat embryos leading to tibial ray deficiencies induced by busulfan.
Topics: Animals; Antineoplastic Agents, Alkylating; Bone Morphogenetic Protein 4; Bone Morphogenetic Proteins; Bromodeoxyuridine; Busulfan; Cell Differentiation; Cell Division; Fibroblast Growth Factor 8; Fibroblast Growth Factors; Hedgehog Proteins; Immunohistochemistry; In Situ Nick-End Labeling; Rats; Teratogens; Tibia; Trans-Activators | 2005 |
Busulfan-induced senescence is dependent on ROS production upstream of the MAPK pathway.
Topics: Acetylcysteine; Antineoplastic Agents, Alkylating; beta-Galactosidase; Blotting, Western; Bromodeoxyuridine; Busulfan; Cell Proliferation; Cells, Cultured; Cellular Senescence; Enzyme Activation; Enzyme Inhibitors; Extracellular Signal-Regulated MAP Kinases; Fibroblasts; Glutathione; Humans; Lung; Mitogen-Activated Protein Kinases; NADPH Oxidases; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Reactive Oxygen Species; Signal Transduction; Tumor Suppressor Protein p53 | 2007 |
Effect of human recombinant granulocyte colony-stimulating factor on rat busulfan-induced testis injury.
Topics: Animals; Bromodeoxyuridine; Busulfan; Cell Survival; DEAD-box RNA Helicases; DNA-Binding Proteins; Gene Expression Regulation; Granulocyte Colony-Stimulating Factor; Injections, Subcutaneous; Male; Nuclear Proteins; Organ Size; Proliferating Cell Nuclear Antigen; Rats; Rats, Wistar; Recombinant Proteins; RNA-Binding Proteins; Semen Analysis; Signal Transduction; Sperm Count; Spermatogenesis; Testis | 2016 |